Endexx to Launch Collaboration Program in Colorado
June 23 2014 - 7:15AM
Marketwired
Endexx to Launch Collaboration Program in Colorado
Company's Autospense(TM) Technology to Be Tested in Top Denver
Dispensary
CAVE CREEK, AZ--(Marketwired - Jun 23, 2014) - Endexx
Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of
innovative medical marijuana management and technology solutions,
announced today that it has secured a site location to test its
Autospense™ technology in the Colorado market. The dispensary is a
well-known, high volume dispensary licensed in medical and
recreational marijuana sales. The 100-day pilot program is designed
to test for compliance and tracking integration under the Medical
Marijuana Infused Products Manufacturing License program ("MIPS")
regulated by the Marijuana Enforcement Division of Colorado. During
the program, a goal is to collect measurable data on dispensary
clients' behavior, market test adoption drivers and collect
valuable intelligence on the ways Autospense can enhance
profitability to store owners, offset labor costs, assist in
inventory management, eliminate client wait time and increase
customer loyalty and satisfaction.
The program will be put in
place for an initial 100 day trial period, followed by a lease
option on the equipment. Endexx is pursuing similar market testing
ventures with dominant licensed retailers in newly legalized
markets.
Endexx's Autospense™ is a high-tech marijuana inventory control
and dispensing machine, which provides up to the minute accounting
details, monitoring and tracking of inventory, and provides
verification and safety for the product as well as patients and
customers of the dispensaries. Autospense™ increases productivity
and reduces costs for marijuana retailers, while enhancing their
service quality by reducing transaction time for customers. Endexx
will be displaying the Autospense™ at the Weedstock Conference on
June 30-July 2, 2014. After the conference has commenced, the unit
will be shipped to the dispensary in Colorado. Endexx will announce
more details of the launch following the conference.
"After intensive research and development we are very excited to
launch Autospense™ into the first dispensary," said Todd Davis,
Founder and CEO of Endexx Corporation. "Pharmaceutical-grade
compliance is essential for the success of both the medical and
recreational marijuana industries. Autospense™ is ideal for any
dispensary and offers a cutting-edge solution that maintains full
compliance with regulations. This launch is a huge milestone for us
and positions us perfectly to grow within the industry. This is
only the beginning as we look to roll out more Autospense™ machines
in the coming months."
About Endexx Endexx provides innovative medical marijuana
management and technology solutions. The company has two products
that launched in the first half of 2014 -- the M3hub and the
Autospense™. Both products provide essential solutions to promote
regulatory compliance and full accountability through "seed to
sale" inventory management, process monitoring and tracking. Based
on principles developed by the pharmacological industry, the m3hub
database is the first standardized software platform for tracking
pharmaceutical grade marijuana to support a Centralized Medical
Marijuana Industry Repository and maintain compliance with the laws
of the federal government and state and local regulatory bodies.
The Autospense™ is a high-tech marijuana inventory control and
dispensing machine, which provides up to the minute accounting
details and protects the security of the product as well as the
patient. By automating the dispensing process, Autospense™
increases productivity and reduces costs for marijuana retailers,
while enhancing their service quality by reducing transaction time
for customers. www.endexx.com, www.m3hub.com,
www.autospense.com
Safe Harbor Notice This press release may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995, such as statements
relating to financial results and plans for future development
activities, and are thus prospective. Forward-looking statements
include all statements that are not statements of historical fact
regarding intent, belief or current expectations of the Company,
its directors or its officers. Investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, many of which are
beyond the Company's ability to control. Actual results may differ
materially from those projected in the forward-looking statements.
Among the factors that could cause actual results to differ
materially from those indicated in the forward-looking statements
are risks and uncertainties associated with the Company's business
and finances in general, including the ability to continue and
manage its growth, competition, global economic conditions and
other factors discussed in detail in the Company's periodic filings
with the Security and Exchange Commission. The Company undertakes
no obligation to update any forward-looking statements.
CONTACT: For further investor and media information, contact:
Endexx Corporation Todd Davis Chairman & CEO endexx@endexx.com
480-595-6900 IRTH
Communications Robert Haag Managing Director
edxc@irthcommunications.com 866-976-4784
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Endexx (PK) (USOTC:EDXC)
Historical Stock Chart
From Jan 2024 to Jan 2025